PL1948224T3 - Trwały preparat amorficznych soli peryndoprylu, sposób ich wytwarzania, zwłaszcza wytwarzania w skali przemysłowej oraz ich zastosowanie w terapii nadciśnienia - Google Patents

Trwały preparat amorficznych soli peryndoprylu, sposób ich wytwarzania, zwłaszcza wytwarzania w skali przemysłowej oraz ich zastosowanie w terapii nadciśnienia

Info

Publication number
PL1948224T3
PL1948224T3 PL06813152T PL06813152T PL1948224T3 PL 1948224 T3 PL1948224 T3 PL 1948224T3 PL 06813152 T PL06813152 T PL 06813152T PL 06813152 T PL06813152 T PL 06813152T PL 1948224 T3 PL1948224 T3 PL 1948224T3
Authority
PL
Poland
Prior art keywords
preparation
hypertension
therapy
stable formulation
especially industrial
Prior art date
Application number
PL06813152T
Other languages
English (en)
Inventor
Rudolf Rucman
Pavel Zupet
Original Assignee
Silverstone Pharma Est
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200600177A external-priority patent/SI22339A/sl
Application filed by Silverstone Pharma Est filed Critical Silverstone Pharma Est
Publication of PL1948224T3 publication Critical patent/PL1948224T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
PL06813152T 2005-11-17 2006-11-08 Trwały preparat amorficznych soli peryndoprylu, sposób ich wytwarzania, zwłaszcza wytwarzania w skali przemysłowej oraz ich zastosowanie w terapii nadciśnienia PL1948224T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SI200500314 2005-11-17
SI200600177A SI22339A (sl) 2006-07-31 2006-07-31 Stabilna formulacija amorfnega perindopril erbumina, postopek za njeno pripravo v industrijskem merilu in njena uporaba za zdravljenje hipertenzije
PCT/SI2006/000034 WO2007058634A1 (en) 2005-11-17 2006-11-08 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension
EP06813152.3A EP1948224B1 (en) 2005-11-17 2006-11-08 Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension

Publications (1)

Publication Number Publication Date
PL1948224T3 true PL1948224T3 (pl) 2014-10-31

Family

ID=37801135

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06813152T PL1948224T3 (pl) 2005-11-17 2006-11-08 Trwały preparat amorficznych soli peryndoprylu, sposób ich wytwarzania, zwłaszcza wytwarzania w skali przemysłowej oraz ich zastosowanie w terapii nadciśnienia

Country Status (9)

Country Link
EP (1) EP1948224B1 (pl)
HR (1) HRP20140476T1 (pl)
ME (1) ME01879B (pl)
PL (1) PL1948224T3 (pl)
PT (1) PT1948224E (pl)
RS (1) RS53324B (pl)
RU (1) RU2429878C2 (pl)
SI (1) SI1948224T1 (pl)
WO (1) WO2007058634A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI22542A (sl) * 2007-06-04 2008-12-31 Diagen D.O.O. Stabilna formulacija amorfnih soli perindoprila, postopek za njeno pripravo v industrijskem merilu in njena uporaba za zdravljenje hipertenzije
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
MX2020009699A (es) 2009-04-03 2021-12-17 Ocera Therapeutics Inc Fenil acetato de l-ornitina y metodos para elaborar el mismo.
JP6087284B2 (ja) 2010-10-06 2017-03-01 オセラ セラピューティクス， インコーポレイテッド Ｌ−オルニチンフェニルアセテートを製造するための方法
WO2016178591A2 (en) 2015-05-05 2016-11-10 Gene Predit, Sa Genetic markers and treatment of male obesity

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
SI9111842A (sl) * 1991-11-25 1998-04-30 Krka Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
US20040014680A1 (en) * 2000-10-16 2004-01-22 Hiroaki Nakagami Medicinal compositions quickly disintegrating in the oral cavity and process for producing the same
WO2003075842A2 (en) * 2002-03-08 2003-09-18 Teva Pharmeceuticals Usa, Inc. Stable formulations of angiotensin converting enzyme (ace) inhibitors
SI21703A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
SI21704A (en) * 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd New crystal form of perindopril, procedure of its preparation, pharmaceutical preparations containing this form and their application in treatment of hypertensia
EP1729739B1 (en) 2004-03-29 2016-09-28 Les Laboratoires Servier Process for preparing a solid pharmaceutical composition

Also Published As

Publication number Publication date
SI1948224T1 (sl) 2014-07-31
RU2429878C2 (ru) 2011-09-27
EP1948224A1 (en) 2008-07-30
HRP20140476T1 (hr) 2014-07-18
EP1948224B1 (en) 2014-03-12
RS53324B (en) 2014-10-31
PT1948224E (pt) 2014-06-12
RU2008123615A (ru) 2009-12-27
WO2007058634A1 (en) 2007-05-24
WO2007058634B1 (en) 2007-07-26
ME01879B (me) 2014-12-20

Similar Documents

Publication Publication Date Title
HK1095146A1 (en) Aminopyrimidine compounds and their salts, process for preparation and pharmaceutical use thereof
IL192053A (en) 2-Admentiluria derivatives as selective inhibitors of 1hsd-β11 and their use in drug preparation
IL233925A0 (en) Pharmaceutical dose for oral administration in the form of tiny particles to prevent incorrect use
IL196854A (en) Indole compounds and their appropriate pharmaceutical salts and their use in the preparation of @ drugs
EP1928802B8 (de) In wasser redispergierbares pulver, verfahren zu dessen herstellung und dessen verwendung
HK1118798A1 (en) Phenyl-containing n-acyl amine and aminoacid derivatives, methods for the production thereof, a pharmaceutical composition and the use thereof -n-
IL216516A0 (en) Nitrooxy derivatives of glucocorticoids, process for their preparation and use thereof in the manufacture of medicaments
HUP0500921A2 (en) Tetrazole derivatives, process for their preparation and their use
SI1718340T1 (sl) Novi efektorski konjugati, postopek za njihovo proizvodnjo in njihova farmacevtska uporaba
SI2020410T1 (sl) Derivati pirido(2,3-d)pirimidina, njihova priprava, njihova terapevtska uporaba
ZA200808754B (en) Tetrahydronaphthaline derivatives, methods for the production and use hereof as anti-inflammatory agents
PT1948224E (pt) Preparação industrial, e a sua utilização na terapêutica da hipertensão
IL183163A0 (en) Sulfonamido-macrocycles as tie2 inhibitors and the salts thereof, a pharmaceutical composition comprising these compounds, the method of preparing and the use thereof
SI1753720T1 (sl) Postopek za pripravo perindoprila in njegovih soli
ZA200803445B (en) 6-heteroarylpyridoindolone derivatives, their preparation and therapeutic use thereof
IL190596A0 (en) 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
IL198481A0 (en) Pyrrole derivatives, preparation use of the same in therapy
IL190334A0 (en) Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents
ZA200803889B (en) Stable formulation of amorphous perindopril salts, a process for their preparation, especially industrial preparation, and their use in the therapy of hypertension
IL188185A0 (en) Phenylpyridine derivatives, their manufacture and use as pharmaceutical agents
IL187419A0 (en) Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
EP1743896A3 (en) A process for the purification of imiquimod
AU2005905699A0 (en) Salts and process for preparing same
AU2004905892A0 (en) Salts and process for preparing same
GB0807094D0 (en) 4,4-dimethylpiperidine-2, 6-dione derivatives for use in the treatment of hypertension